OpGen

OpGen is a Maryland-based biotechnology company that researches and develops molecular diagnostic therapeutics for the treatment of infectious diseases.

Business Model:

Revenue: $3.4M

Employees: 51-200

Detailed OpGen Information

Geographic Data

OpGen headquarters map

Address: 9717 Key West Avenue

City: Rockville

State: MD

Zip: 20850

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$15M

Raised Total:

$138M

Metrics

4,521,532Website Global Rank

2,347Website Monthly Traffic

Twitter Followers

Description

OpGen is a Maryland-based biotechnology company that researches and develops molecular diagnostic therapeutics for the treatment of infectious diseases.

Contact Phone:
+13018699683

Contact Email:

OpGen went public on 4/24/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/24/2015

Ticker Symbol:
OPGN

IPO Price:
$5.5/share

Amount Raised:
$16M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
3/2012 BioRelix Venture Round 2.6M
3/2012 BioRelix Venture Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors
2/2015 Debt Financing $1.2M
7/2015 Post-IPO Equity 1 $6M Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
2/2018 Post-IPO Equity $12M
7/2017 Post-IPO Equity $10M
3/2019 Post-IPO Equity $5.4M
5/2016 Post-IPO Equity 2 $10.4M Merck Global Health Innovation Fund
Sabby Management
Merck Global Health Innovation Fund
Sabby Management
Merck Global Health Innovation Fund
Sabby Management
Merck Global Health Innovation Fund
Sabby Management
11/2020 Post-IPO Equity $10M
10/2021 Post-IPO Equity $15M
10/2019 Post-IPO Equity $9.4M
7/2014 Debt Financing $1.1M
9/2010 Series B $0 CHL Medical Partners
Highland Capital Partners
jVen Capital
Mason Wells
Versant Ventures
CHL Medical Partners
Highland Capital Partners
jVen Capital
Mason Wells
Versant Ventures
1/2010 Debt Financing $4.1M
3/2012 Series C $0 180 Degree Capital
CHL Medical Partners
Cross Creek
Highland Capital Partners
jVen Capital
Versant Ventures
180 Degree Capital
CHL Medical Partners
Cross Creek
Highland Capital Partners
jVen Capital
Versant Ventures
1/2023 Post-IPO Equity $7.5M
10/2022 Post-IPO Equity $3.4M
4/2020 Debt $879.6k Silicon Valley Bank
Small Business Administration
4/2020 Debt $350k U.S. Small Business Administration.
9/2022 Post-IPO Equity $3.4M
1/2023 Post-IPO Equity $7.5M
2/2012 Debt Financing $3.5M
5/2010 Debt Financing $4M
4/2014 Debt Financing $4M
1/2005 Series B $0 Mason Wells
Wisconsin Alumni Research Foundation
Stonehenge Capital
State of Wisconsin Investment Board
Mason Wells
Wisconsin Alumni Research Foundation
Stonehenge Capital
State of Wisconsin Investment Board
9/2007 Venture Round $0 Mason Wells
Versant Ventures
In-Q-Tel
Highland Capital Partners
CHL Medical Partners
Mason Wells
Versant Ventures
In-Q-Tel
Highland Capital Partners
CHL Medical Partners
Announced Date Name Price
7/2015 AdvanDx

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research